Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 42.18M P/E - EPS this Y 17.50% Ern Qtrly Grth -
Income -35.33M Forward P/E -1.49 EPS next Y - 50D Avg Chg 12.00%
Sales 6.81M PEG - EPS past 5Y - 200D Avg Chg -38.00%
Dividend N/A Price/Book 0.38 EPS next 5Y - 52W High Chg -81.00%
Recommedations 3.00 Quick Ratio 10.24 Shares Outstanding 31.26M 52W Low Chg 41.00%
Insider Own 2.68% ROA -24.44% Shares Float 30.41M Beta -0.68
Inst Own 15.65% ROE -35.24% Shares Shorted/Prior 496.50K/341.33K Price 1.37
Gross Margin 38.57% Profit Margin - Avg. Volume 126,853 Target Price 2.50
Oper. Margin -332.62% Earnings Date May 9 Volume 71,981 Change -2.49%
About Co-Diagnostics, Inc.

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Co-Diagnostics, Inc. News
04/12/24 Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event
04/04/24 Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions
03/21/24 Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote Address
03/18/24 Co-Diagnostics, Inc. CEO to Deliver Keynote Address at MarketsandMarkets 2024 in London, England
03/16/24 We Think Co-Diagnostics (NASDAQ:CODX) Needs To Drive Business Growth Carefully
03/16/24 Co-Diagnostics Full Year 2023 Earnings: Misses Expectations
03/15/24 Co-Diagnostics, Inc. (NASDAQ:CODX) Q4 2023 Earnings Call Transcript
03/15/24 Q4 2023 Co-Diagnostics Inc Earnings Call
03/14/24 Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results
03/07/24 Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test
02/29/24 Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Webcast
02/01/24 Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for February 2024
01/03/24 Co-Diagnostics, Inc. to Host Booth at CES 2024 January 9-12
12/27/23 Co-Diagnostics, Inc. Completes Submission to FDA for Co-Dx PCR Pro
11/29/23 Co-Diagnostics, Inc. to Participate in the Piper Sandler 35th Annual Healthcare Conference in New York City on November 30, 2023
11/10/23 Co-Diagnostics, Inc. (NASDAQ:CODX) Q3 2023 Earnings Call Transcript
11/10/23 Q3 2023 Co-Diagnostics Inc Earnings Call
11/09/23 Co-Diagnostics, Inc. Reports Third Quarter 2023 Financial Results
11/02/23 Co-Diagnostics, Inc. Announces Additional Grant Award for Tuberculosis Test in Development
10/31/23 Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for November 2023
CODX Chatroom

User Image WhoElseButQuagmire Posted - 4 hours ago

$CODX holding on tight.

User Image Millones Posted - 7 hours ago

$CODX

User Image Tgaak Posted - 9 hours ago

$CODX The World Health Organization (WHO) was notified about a case of human infection with an influenza A(H9N2) virus in Viet Nam on 9 April 2024 by the International Health Regulations (IHR) National Focal Point (NFP). The patient, who had underlying conditions and was in severe condition was admitted to the intensive care on 21 March 2024. A respiratory sample was collected on 21 March and tested positive for influenza by Real-Time Polymerase Chain Reaction (PCR). Subsequently, virus subtyping confirmed avian influenza A(H9N2) on 8 April. As of 15 April, there have been no reports of new cases with respiratory symptoms among contacts of the case or outbreaks in the community where the case resides. This is the first human infection with an avian influenza A(H9N2) virus reported in Viet Nam. According to the IHR (2005), a human infection caused by a novel influenza A virus subtype is an event that has the potential for high public health impact and must be notified to the WHO.

User Image Pyranha Posted - 12 hours ago

$CODX welp there goes another week without news. surely it will be next week……… surely

User Image Minutiae Posted - 1 day ago

$CODX FINRA Apr 18 CODX short volume 23% out of a 216,448 trade volume.

User Image STRAYNUT Posted - 1 day ago

$CODX Naked Short Report Daily https://www.nakedshortreport.com/company/CODX

User Image codiamond Posted - 1 day ago

$CODX Can somebody post our short volume stats since our ribbon cutting. I think I remember a fairly sharp drop off in shorting right away. It might be interesting to see what happened when the suspicious "ask" activity began. I don't trade options, but if options expire tomorrow, as another poster has stated here, then somebody with some clout should phone the SEC. IMO

User Image codiamond Posted - 1 day ago

$CODX Hang on. This post was over on Yahoo: "12 hours ago Apr 17 short volumes: codx 77%, flgt 46%, hlth 46%, qdel 71%, veru 39%. This data is provided only for investor assessment of short activity in this health sector and not for promotional purposes." Can/could/would Market Making Firms also be allowed to heavily short a security for which their responsibility is to provide an orderly market? Major intervention and market distortion don't seem appropriate if that is happening. IMO

User Image codiamond Posted - 1 day ago

$CODX Hard to ignore today's action. What does it mean? IDK

User Image Minutiae Posted - 1 day ago

$CODX Looks like those 97,321 shares were sold. Today's volume is now up to 172,961.

User Image Tgaak Posted - 1 day ago

$CODX Options expiration tomorrow. or could it be … oh yeah it‘s Codx

User Image Minutiae Posted - 1 day ago

$CODX 97,000 it is. codx - Cboe Exchange Book Viewer https://www.cboe.com/us/equities/market_statistics/book/codx/

User Image Hammarclavier Posted - 1 day ago

$CODX sometimes I ask me why this company went public needing to get listed on the Nasdaq.

User Image Minutiae Posted - 1 day ago

$CODX The ask is 973, NOT 97,000.

User Image OptimistJP Posted - 1 day ago

$CODX 97,000 on the ask at $1.11. Set up for shorts?

User Image Millones Posted - 1 day ago

$CODX Premarket LVLII

User Image Minutiae Posted - 1 day ago

$CODX Apr 17 CODX short volume 77% out of a 33,168 trade volume. Weird...🙄

User Image LondonVentures Posted - 1 day ago

$CODX …how that next quarterly should start off…so us retailers start getting our value back

User Image codiamond Posted - 2 days ago

$CODX That strange ask action has me hoping that it didn't have anything to do with some person or thing that is standing too close to the table...

User Image Millones Posted - 2 days ago

$CODX Fascinating that those shares on the ask were not touched. Tomorrow is a new day, and maybe we find out why they were there. Time will tell. Tick tock

User Image Millones Posted - 2 days ago

$CODX Biopharma Therapeutics Licensing Deals and Venture Some good for thought while we wait… https://www.jpmorgan.com/content/dam/jpm/commercial-banking/insights/life-sciences/JPMorgan-Q1-2022-BioPharma-FINAL.pdf

User Image Minutiae Posted - 2 days ago

$CODX Yahoo Finance gives the CODX Q1 2024 Earnings Date as: May 9, 2024 - May 13, 2024. May 9 occurs on a Thursday which makes it the most likely earnings date. So, following the April 11 ribbon cutting ceremony, is Co-Dx now in another "quiet period" ahead of earnings? There hasn't even been a Co-Dx "Africa 2024 Medexpo" PR, and the expo is in progress right now. Kinda get the feeling that everybody at Co-Dx has got a case of "EUA on the brain".

User Image OptimistJP Posted - 2 days ago

$CODX not intended at all to discredit the expertise of those posting on this board, but wouldn't it be great to have a poster who knew what is going on?

User Image Millones Posted - 2 days ago

$CODX Interesting ask….

User Image encostock Posted - 2 days ago

$CODX but here the strange thing is an EUA approval which after 4 months is still not approved... something doesn't add up

User Image OptimistJP Posted - 2 days ago

$CODX so far today, buy volume 1, sell volume 9,068. No comment necessary or appropriate for a public board.

User Image encostock Posted - 2 days ago

$CODX

User Image Tgaak Posted - 2 days ago

$CODX WASHINGTON — President Joe Biden’s administration will help 50 countries identify and respond to infectious diseases, with the goal of preventing pandemics like the Covid-19 outbreak that suddenly halted normal life around the globe in 2020. U.S. government officials will offer support in the countries, most of them located in Africa and Asia, to develop better testing, surveillance, communication, and preparedness for such outbreaks in those countries.

User Image Ally420 Posted - 3 days ago

$CODX last year, q1 earnings was Thursday May 11. Hard to believe that's only 25 days away. Time 🪰s

User Image Minutiae Posted - 3 days ago

$CODX FINRA Apr 16 CODX short volume 17% out of a 35,533 trade volume.

Analyst Ratings
HC Wainwright & Co. Neutral Mar 15, 24
HC Wainwright & Co. Neutral Dec 29, 23
HC Wainwright & Co. Neutral Nov 13, 23
HC Wainwright & Co. Neutral Aug 14, 23
HC Wainwright & Co. Neutral May 15, 23
HC Wainwright & Co. Neutral Mar 20, 23
HC Wainwright & Co. Buy Feb 23, 23
HC Wainwright & Co. Buy Nov 14, 22
HC Wainwright & Co. Buy Aug 15, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Brown Brian Lee Chief Financial Offi.. Chief Financial Officer Mar 20 Buy 1.899 3,000 5,697 76,236 03/21/23
Egan Dwight H Chief Executive Offi.. Chief Executive Officer Jan 20 Option 2.63 50,000 131,500 50,000 01/20/21
Egan Dwight H Chief Executive Offi.. Chief Executive Officer Jan 20 Sell 11 38,046 418,506 01/20/21
Egan Dwight H Chief Executive Offi.. Chief Executive Officer Nov 25 Option 1.1 150,000 165,000 50,000 11/25/20
Egan Dwight H Chief Executive Offi.. Chief Executive Officer Nov 25 Sell 10.68 134,350 1,434,858 11/25/20